Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Chosa Oncology AB
AB
Active
Org 5590372271
Kungsgatan 6, 211 49
Malmö
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 10 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Chosa Oncology AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2020: 2M
2M
2020
2021: 2M (0% vs 2020)
2M
0%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-2M
-5M
-7M
-10M
2020: -8M
-8M
2020
2021: -8M (0% vs 2020)
-8M
0%
2021
2022: -8M (0% vs 2021)
-8M
0%
2022
2023: -5M (+38% vs 2022)
-5M
+38%
2023
2024: -3M (+40% vs 2023)
-3M
+40%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
73
1 977
1 964
2 037
Staff expenses
—
—
—
—
—
EBITDA
−3 271
−5 227
−7 706
−8 469
−7 778
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−3 271
−5 227
−7 706
−8 469
−7 778
Net financials
270
−350
−156 454
107
−39
Profit before tax
−3 001
−5 578
−164 160
−8 362
−7 778
Tax
−0
−0
−0
−0
−0
Net profit
−3 001
−5 578
−164 160
−8 362
−7 778
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
56 167
54 949
25 845
174 108
182 369
Equity
52 078
49 545
7 709
171 869
179 761
Long-term debt
0
0
0
0
0
Short-term debt
4 088
5 404
18 136
2 240
2 608
Total debt
4 088
5 404
18 136
2 240
2 608
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
92,7 %
This company
38,2 %
Market median
This company
Market median
143% above market
2020
2024
Return on equity
−5,8 %
This company
18,4 %
Market median
This company
Market median
132% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,08×
This company
0,62×
Market median
This company
Market median
87% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Chosa Oncology AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
